| VRT |
Report |
2Q26 revenue |
BEAT |
pred ~$3.47B vs. cons $3.39B |
MEDIUM |
| VRT |
Report |
2Q26 adjusted EPS |
BEAT |
pred ~$1.48 vs. cons $1.43 |
MEDIUM |
| VRT |
Report |
2Q26 adjusted operating margin |
IN-LINE |
pred ~21.8% vs. cons 21.6% |
MEDIUM |
| VRT |
Guide |
FY26 revenue guidance |
BETTER |
guide ~$14.15B vs. cons $14.03B (FY26) |
MEDIUM |
| VRT |
Guide |
FY26 adjusted EPS guidance |
BETTER |
guide ~$6.60 vs. cons $6.48 (FY26) |
MEDIUM |
| VRT |
Guide |
FY26 adjusted operating-margin guidance |
BETTER |
guide ~23.6% vs. cons 23.5% (FY26) |
LOW |
| VRT |
Return |
Day-1 residual (stock − beta × S&P 500) |
+6.5% |
— |
MEDIUM |
| VRT |
Return |
5-day cumulative residual |
+9.5% (FOLLOW-THROUGH) |
A ~$1.48 EPS result versus $1.43 consensus and FY26 EPS guide of ~$6.60 versus $6.48 would lift second-half and 2027 earnings assumptions; revenue guide of ~$14.15B versus $14.03B supports continued estimate revisions rather than a one-day technical beat. |
MEDIUM |